Loss of Arp2/3 induces an NF-κB–dependent, nonautonomous effect on chemotactic signaling by Wu, Congying et al.
The Rockefeller University Press  $30.00
J. Cell Biol. Vol. 203 No. 6 907–916
www.jcb.org/cgi/doi/10.1083/jcb.201306032 JCB 907
JCB: Report
Correspondence to James E. Bear: jbear@email.unc.edu
Abbreviations used in this paper: CI, confidence interval; CM, conditioned 
media; FN, fibronectin; HGF, hepatocyte growth factor; IKK, IB kinase; KD, 
knockdown; MEF, mouse embryonic fibroblast; NF-B, nuclear factor B; NS, 
nonspecific; PDMS, polydimethylsiloxane; qRT-PCR, quantitative RT-PCR; SASP, 
senescence-associated secretory phenotype.
Introduction
The seven-subunit Arp2/3 complex is critical for generating a 
unique branched actin network underneath the plasma mem-
brane. Arp2/3 complex binds to existing actin filaments and 
initiates actin daughter filaments as branches off of the mother 
filaments, creating new actin branches with an angle of 70° 
(Pollard, 2007). The branched actin network generated by Arp2/3 
complex is controlled by multiple signaling pathways and is 
regulated by multiple actin binding proteins (Pollard, 2007; 
Rotty et al., 2013).
Recent progress has been made in understanding the cel-
lular function of Arp2/3. Using Arp2/3-deficient mammalian cells, 
two groups showed that Arp2/3-branched actin is essential for 
forming lamellipodia and maintaining random migration speed 
(Suraneni et al., 2012; Wu et al., 2012). Because leading edge 
protrusions have been implicated in directed migration, the ef-
fects of Arp2/3 depletion have also been examined in the context 
of haptotaxis and chemotaxis. With a stable fibroblast cell line 
depleted of two subunits of the Arp2/3 complex (p34Arc and 
Arp2, referred to as 2× knockdown [KD] cells throughout), we 
showed that the branched actin network is essential for sensing 
and/or responding to changes in extracellular matrix concentra-
tion (haptotaxis). Divergent results were reported concerning the 
role of Arp2/3 in chemotaxis. Using microfluidic devices allow-
ing media exchange, we showed that Arp2/3 complex was not 
essential for fibroblast chemotaxis up PDGF gradients, suggest-
ing important differences in the molecular machinery of chemo-
taxis versus haptotaxis (Wu et al., 2012). However, Suraneni 
et al. (2012) reported that Arp2/3 was required for EGF chemo-
taxis. Thus, the role of Arp2/3-branched actin in sensing and re-
sponding to a soluble gradient remains unresolved.
Cellular senescence is characterized by a state of perma-
nent growth arrest via the up-regulation of p16INK4a and ARF, 
two linked tumor suppressors encoded by the INK4a/ARF locus 
(Sharpless, 2004). The surprising viability of 2×KD cells was 
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as chemotaxis, may be affected in a nonautonomous manner 
depending on the experimental regimen. Given that Arp2/3- 
deficient cells secrete increased levels of growth factors, such as 
hepatocyte growth factor (HGF), we reasoned the apparent dis-
crepancy in the need for Arp2/3 in fibroblast chemotaxis could 
be caused by differences in media exchange in the respective 
chemotactic chamber designs (closed [Suraneni et al., 2012] vs. 
continuous flow [Wu et al., 2012]). To mimic the closed cham-
ber design, we used conditioned media (CM) in our continu-
ous flow chambers. CM from the Arp2/3-depleted cells (2×KD) 
blocked EGF chemotaxis in both control (nonspecific [NS]) and 
2×KD cells, but NS CM did not affect this process in either 
cell line (Fig. 2 A). To test whether CM affected EGF signal-
ing, we compared AKT activation (p-AKT) levels of NS and 
2×KD cells after EGF stimulation in the different media. In the 
presence of 2×KD CM, both cell types had a high basal level 
of AKT activation that could not be further stimulated by EGF 
(Fig. 2 B). Together, these results indicate that 2×KD CM dis-
rupts normal EGF signaling sensitivity and perturbs the abil-
ity of fibroblasts to migrate up an EGF gradient. Interestingly, 
2×KD CM did not show the same effect on PDGF chemotaxis 
or signaling (Fig. 2, C and D), suggesting that this pathway is 
relatively insensitive to the factors contained in the 2×KD CM. 
To establish that the effects of 2×KD CM are reversible, we 
replaced 2×KD CM with control CM midway through an EGF 
experiment and observed a restored chemotactic response upon 
the shift (Fig. 2 E).
Depletion or inhibition of Arp2/3  
leads to NF-B activation
The SASP response has been reported to occur with DNA dam-
age, oncogene activation, and cellular stress and is regulated 
by the NF-B pathway (Karin, 2006; Chien et al., 2011; Freund 
et al., 2011). Thus, we postulated that the loss of Arp2/3 would 
lead to activation of NF-B. Using phosphorylated RelA/p65 
(p-p65) as a surrogate marker for NF-B activity, we detected 
strong activation in Arp2/3-depleted cells (Fig. 3 A) and in mul-
tiple cell lines treated with the Arp2/3 inhibitor CK666 but not 
the inactive CK689 compound (Fig. 3 B and Fig. S1 A). We 
previously confirmed the specificity of this inhibitor using mo-
tility assays (Wu et al., 2012), and in this context, we were able 
to use it to carefully control the timing of Arp2/3 inhibition. We 
also observed increased nuclear localization of p-p65 in 2×KD 
cells, consistent with elevated nuclear NF-B activity (Fig. 3 C). 
The cytoplasmic staining observed with this antibody was con-
firmed to be NS background using p65/ mouse embryonic 
fibroblasts (MEFs; Fig. S1 F). Using an IB kinase (IKK) in-
hibitor (cmpdA; Stein and Baldwin, 2011), we observed that the 
elevated p-p65 level in 2×KD cells could be reduced, suggesting 
that a canonical NF-B activation pathway was involved (Fig. 3 D). 
This same treatment decreased the expression of several of 
the secreted factors by qRT-PCR and ELISA (Fig. S1, B and C). 
Importantly, this treatment did not affect the reduced migration 
speed or altered cell morphology that we reported previously 
with loss of Arp2/3 activity (Fig. S1, D and E; Wu et al., 2012). 
Together, these results indicate that loss of Arp2/3 activity leads 
to the activation of a canonical NF-B pathway.
caused, in part, by the genetic background effects of the loss 
of Ink4a/Arf tumor suppressors (Wu et al., 2012), suggesting 
that the loss of Arp2/3 may induce senescence in an Ink4a/Arf- 
dependent manner. Senescent cells also display altered expres-
sion of certain proteins, including the transcription up-regulation 
of multiple proinflammatory secreted factors, a response known 
as the senescence-associated secretory phenotype (SASP; Campisi 
and d’Adda di Fagagna, 2007; Salminen et al., 2012). Emerging 
data indicate that this SASP response causes nonautonomous 
effects on disease states such as cancer (Salminen et al., 2012; 
Lujambio et al., 2013). The nuclear factor B (NF-B) and p38 
MAPK pathways have been shown to play important roles in 
regulating SASP (Coppé et al., 2008; Freund et al., 2011; Salminen 
et al., 2012; Tchkonia et al., 2013).
In the present study, we compared the global transcrip-
tional profiles of cells with and without the Arp2/3 complex 
and observed an induction of a SASP gene expression response 
upon Arp2/3 depletion. We also demonstrate that the secreted 
factors released by Arp2/3-depleted cells affect EGF chemotaxis 
in a nonautonomous way. Our results resolve the conflicting ob-
servations about the role of Arp2/3 in chemotaxis and suggest 
that experimental manipulations affecting the Arp2/3-branched 
actin may have both autonomous effects on the cytoskeleton and 
potential nonautonomous effects, such as confounding inflam-
matory responses.
Results and discussion
Depletion of Arp2/3 complex induces 
expression of SASP genes
To further understand the role of Arp2/3-branched actin on over-
all cellular physiology, we performed whole transcriptome RNA-
Seq–based expression profiling of the stable Arp2/3-depleted cells 
we established previously (2×KD cells; Wu et al., 2012). There 
was no significant pattern of altered expression in genes of the 
serum response factor pathway that had previously been linked 
to changes in F-actin content (Posern and Treisman, 2006; Olson 
and Nordheim, 2010). However, we detected an unexpected in-
crease in the expression of many genes encoding secreted proteins 
such as chemokines, growth factors and matrix metalloprotein-
ases, a pattern very similar to the SASP gene expression signature 
(Fig. 1 A and Table S1; Coppé et al., 2008; Kuilman et al., 2008; 
Salminen et al., 2012). To analyze the altered genes in an unbi-
ased manner, we conducted DAVID (Database for Annotation, 
Visualization, and Integrated Discovery) analysis of the top 500 
genes increased in the 2×KD cells (Huang et al., 2009). Based on 
this analysis, the list of up-regulated genes contains an over-
representation of immune and inflammatory genes (Fig. 1 B). 
The RNA-Seq results were confirmed for a subset of the genes at 
the transcript level by quantitative RT-PCR (qRT-PCR; Fig. 1 C) 
and at the protein level by ELISA (Fig. 1 D).
Secreted factors released by Arp2/3-
depleted cells cause nonautonomous 
effects on EGF signaling and chemotaxis
One functional consequence of the change in secreted proteins 
upon Arp2/3 depletion is that signaling/motility processes, such 
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Figure 1. Arp2/3-depleted cells show increased expression of SASP pathway genes. (A) The transcriptomes of IA32 control fibroblasts and their Arp2/3-
depleted derivatives (2×KD) were analyzed by RNA-Seq. Representative genes of the serum response factor and SASP pathways selected from the RNA-
Seq data (Table S1) are shown. Fold change represents the fold increase in expression (RPKM) for 2×KD cells from control cells, with negative numbers 
representing the fold decrease in expression. (B) DAVID analysis of the top 500 genes (>10-fold up-regulated) with the highest fold increase in 2×KD cells, 
showing overrepresented gene groups as ranked by Benjamini score. (C) qRT-PCR showing fold changes of a subset of cytokines, growth factors, and ma-
trix metalloproteinases up-regulated in 2×KD cells in the RNA-Seq. Two biological replicates (three technical replicates each) for each sample are shown. 
(D) ELISA showing levels of secreted IL-6, MMP3, and HGF in NS and 2×KD cells. Error bars show 95% confidence interval (CI). ****, P < 0.001; 
**, P < 0.01 by Student’s t test.
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cells with CK666 and observed no increased activation of 
NF-B (Fig. 4 D). To determine how specific MEKK3 is for this 
pathway, we added CK666 to cells lacking MEKK2 (the clos-
est protein relative of MEKK3; Maruyama et al., 2010) and 
observed similar NF-B activation to control cells (Fig. S2 C). 
MEKK3 participates in multiple signaling cascades, but CCM2 
(aka OSM) was originally identified as the scaffold for MEKK3 
with F-actin binding capability that is essential for the osmotic 
stress response (Uhlik et al., 2003). To test whether CCM2 is in-
volved in Arp2/3-based regulation of NF-B, we depleted CCM2 
using two distinct siRNAs and observed no activation of NF-B 
in response to CK666 treatment (Fig. 4 E and Fig. S2 D). Pre-
vious work has implicated the CCM2–MEKK3 pathway in 
osmotic stress signaling (Uhlik et al., 2003). Using live-cell im-
aging of tagged CCM2, we observed a transient nuclear translo-
cation of this protein during hyperosmotic response (Fig. 4 E). 
Interestingly, CK666 treatment caused a slower, but more per-
sistent, nuclear translocation of CCM2 (Fig. 4 F), with no di-
minished nuclear signal even after 4 h of treatment (Fig. S2 E). 
Only a portion of CCM2 translocates to the nucleus in either 
case, suggesting that it may participate in multiple protein com-
plexes that are under a different regulatory control. To test for 
The CCM2–MEKK3 pathway is required  
for the NF-B activation induced by  
Arp2/3 inhibition
Previous work has implicated p38 MAPK (p38) as a key up-
stream factor in the activation of the SASP pathway (Freund 
et al., 2011). To test whether p38 is activated by the loss of 
Arp2/3, we blotted for p-p38 (active) and observed elevated 
levels in both Arp2/3-depleted and CK666-treated cells (Fig. 4, 
A and B). To determine whether p38 is upstream of the observed 
NF-B activation in Arp2/3-inhibited cells, we simultaneously 
treated cells with the p38 inhibitor SB203580 and CK666 and 
still observed elevated p-p65, suggesting that p38 is not directly 
upstream in this case (Fig. 4 C). However, consistent with a pre-
vious study (Freund et al., 2011), pretreatment with SB203580 
for >12 h did inhibit CK666’s effect on p-p65 levels (Fig. S2 A), 
suggesting that p38 may indirectly affect this response. More-
over, inhibiting p38 activity reduced the expression levels of 
some but not all of the elevated secreted factors (Fig. S2 B). One 
upstream candidate molecule that activates both IKK–NF-B 
and p38 is the MAPK family member MEKK3 (Schmidt et al., 
2003; Uhlik et al., 2003; Sun and Yang, 2010). We tested whether 
MEKK3 is involved in this pathway by treating MEKK3/ 
Figure 2. Secreted factors from Arp2/3-depleted cells cause nonautonomous effects on chemotaxis. (A) Wind rose plots showing NS and 2×KD cells in 
NS CM or 2×KD CM in EGF chemotaxis. (B) Western blots showing phospho-AKT (p-AKT), total AKT, and GAPDH levels in NS and 2×KD cells upon EGF 
stimulation at the indicated time points. Representative blot from three experiments is shown. Fold changes in band intensity averaged across the three 
experiments (normalized to loading control and experimental control) are shown below each band. (C) Wind rose plots showing NS and 2×KD cells in 
NS CM or 2×KD CM during PDGF chemotaxis. (D) Blot showing p-AKT, total AKT, and GAPDH levels in NS and 2×KD cells upon EGF stimulation at the 
indicated time points. (E) Wind rose plots showing 2×KD cells in EGF chemotaxis, before (right) and after (left) switching from 2×KD CM to NS CM. 2×KD 
cells were plated in a chemotaxis chamber and serum starved overnight before carrying out the EGF chemotaxis experiment in the presence of 2×KD CM. 
After 4 h, 2×KD CM was switched to NS CM, and EGF chemotaxis was continued for another 4 h. Compass parameter and forward migration index are 
indicated on the graphs in A, C, and E; numbers in parentheses show 95% CI.
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of p38, whereas Arp2/3-depleted cells had high basal p38 ac-
tivation that increased upon hyperosmotic stress but never 
decreased, suggesting a defect in adaptation of this response 
without the Arp2/3 complex (Fig. 5 D). Based on the volume 
regulation and signaling defects in cells depleted of the Arp2/3 
complex, we postulated that reducing osmolarity might rescue 
the aberrant stress signaling. Indeed, when we treated Arp2/3-
depleted cells with hypoosmotic media, we observed decreased 
p38 activity within 1 h and decreased NF-B activity within 4 h 
(Fig. 5 E). Therefore, in the absence of Arp2/3, cells appear to 
be unable to adapt to hyperosmotic stress with a physiologi-
cal rapid decrease in volume and exhibit evidence of activated 
signaling associated with a hyperosmotic state even when in 
isotonic media.
The actin cortex is critical for providing mechanical in-
tegrity of the plasma membrane and the homeostasis of cell 
volume in response to osmotic shifts (Moustakas et al., 1998; 
Henson, 1999; Pedersen et al., 2001). Although the actin cor-
tex is central to osmotic adaptation, little is known about how 
cells nucleate, polymerize, and remodel actin networks in the 
cortex (Salbreux et al., 2012). We tested whether the Arp2/3 
complex and branched actin contribute to generating the actin 
cortex. Because imaging the actin cortex is difficult in flat, 
spread cells, we synchronized cells and imaged the cortex of 
cells rounded for mitosis. We detected robust colocalization of 
the Arp2/3 complex with the cortical actin under the plasma 
an interaction between CCM2 and the Arp2/3 complex, we 
immunoprecipitated the Arp2/3 complex from cell lysates and 
blotted for CCM2 (Fig. 4 G). An interaction between these pro-
teins was detected that could be eliminated by pretreating the 
cells with CK666 before lysis, suggesting that active Arp2/3 is 
required for this interaction to occur.
Arp2/3-depleted cells show altered  
osmotic stress response
These observations suggest that Arp2/3-branched actin may 
play a role in osmotic stress responses. Consistent with this idea, 
cells depleted of Arp2/3 complex show significantly higher cell 
death under hyperosmotic conditions (Fig. 5 A). Using live-cell 
imaging, we observed a striking mobilization of the Arp2/3 
complex to the cell periphery in response to hyperosmotic stress 
after 45 min (Fig. 5 B and Video 1). Cells respond to varying os-
motic conditions by dynamic volume regulation (Hoffmann and 
Pedersen, 2006). Whereas control cells decreased their cell vol-
ume in response to hyperosmotic conditions, Arp2/3-depleted 
cells were unable to decrease their cell volume with hyperos-
motic stress but did show enhanced swelling under hypoos-
motic conditions (Fig. 5 C). A well-known signaling cascade 
involving p38 is activated in response to osmotic stress (Nielsen 
et al., 2008). To test the role of Arp2/3 in p38 osmotic signaling, 
we blotted for p-p38 in control and 2×KD cells treated with 
sorbitol. Control cells showed the expected transient activation 
Figure 3. Arp2/3 depletion or inhibition activates the canonical NF-B pathway. (A) Blot showing phospho-p65 (Ser536; p-p65), total p65, and GAPDH 
levels in NS and 2×KD cells. (B) Blot showing p-p65, total p65, and GAPDH levels in NS cells treated with 100 µM CK666 or its inactive control CK689 
for 6 h (right). (C, top) Representative immunofluorescent staining showing p-p65 localization in wild-type (WT) and 2×KD cells. (bottom) Percentages of 
cells having nuclear p-p65 were quantified and graphed. (D) Blot showing p-p65, p65, and GAPDH levels in 2×KD cells treated with an IKK inhibitor 
cmpdA for the indicated times. Fold changes in band intensity averaged across the three experiments (normalized to loading control and experimental 
control) are shown below each band.
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stress signaling. Consistent with this finding, Arp2/3-depleted 
cells are hypersensitive to osmotic stress and display elevated 
activation of this pathway under isotonic conditions. Cells dy-
namically trigger signaling pathways, rearrange cytoskeleton 
networks, and alter their volume, to adapt to varying osmotic 
conditions (Lang, 2007; Descot et al., 2009). Whether Arp2/3-
generated branched actin affects signaling through a scaffolding 
function, by providing mechanical rigidity to the cortex or both, 
remains to be determined. Furthermore, it will be important to 
membrane (Fig. 5 F, i). By comparing the fluorescent profile 
of F-actin in control and 2×KD cells, we observed a significant 
decrease in F-actin intensity at the plasma membrane in 2×KD 
cells compared with controls (Fig. 5 F, ii and iii). These data 
indicate that the Arp2/3 complex plays an important role in 
generating submembranous cortical actin.
In summary, our findings indicate that loss of the Arp2/3 
complex activates the NF-B pathway, downstream of the 
CCM2–MEKK3 pathway, which is also critical for osmotic 
Figure 4. NF-B pathway activation in Arp2/3-depleted or -inhibited cells requires MEKK3 and CCM2. (A) Blot showing phospho–p38 MAPK (Thr180/
Tyr182; p-p38), total p38, and GAPDH levels in NS and 2×KD cells. (B) Blot showing p-p38, total p38, and GAPDH levels in NS cells treated with 
CK689 or CK666 for 6 h (right). (C) Blot showing p-p65, p65, p-HSP27, and GAPDH levels of IA32 cells with 100 µM CK666 only and simultaneous 
10 µM SB203580 + 100 µM CK666 treatments at the indicated time points. Decreased p-HSP27 levels indicate effective inhibition of p-38 activation 
by SB203580. (D) Blot showing p-p65, p65, and GAPDH levels of control and MEKK3/ MEFs upon CK666 treatment for the indicated times. (E) Blot 
showing p-p65, p65, and GAPDH levels of control siRNA and two CCM2 siRNA–treated IA32 cells with CK689 or CK666 treatment for 6 h. (F, left) Time-
lapse images showing representative cells expressing YPET-CCM2 treated in 0.25 M sorbitol (top)- or 100 µM CK666 (bottom)-containing media for the 
indicated times. (right) Quantification of nuclear CCM2 from time-lapse videos. Error bars show 95% CI. (G) Blot showing p34Arc immunoprecipitation (IP) 
experiments of HEK293 FT cells expressing YPET-CCM2 treated with DMSO or CK666 for 6 h before cell lysis. YPET-CCM2 was detected with an anti-GFP 
antibody. Fold changes in band intensity averaged across the three experiments (normalized to loading control and experimental control) are shown below 
each band. A.U., arbitrary unit; IB, immunoblot.
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chemotaxis chamber. However, this concept has much broader 
implications than explaining divergent experimental findings. 
The proinflammatory effects of perturbing Arp2/3 and possibly 
upstream regulatory pathways such as small GTPases (Rac and 
Cdc42) and nucleation-promoting factors (e.g., Scar/WAVE) 
should be taken into consideration when evaluating phenotypes 
of knockout mice and in other experimental systems. Loss of 
proper Arp2/3 regulation may explain inflammatory and auto-
immune phenotypes in human diseases, such as Wiskott-Aldrich 
syndrome, in which mutation of the WAS gene (encoding the 
Arp2/3-activating nucleation-promoting factor Wiskott-Aldrich 
syndrome protein) changes the transcription of inflammatory 
genes in addition to altering cell-autonomous cytoskeletal func-
tions (Dupuis-Girod et al., 2003; Prete et al., 2013).
determine whether senescence is linked to osmotic stress and 
regulation of the actin cortex in other cell types.
Our results also indicate that perturbing Arp2/3-branched 
actin networks leads to the expected cell-autonomous defects 
in cytoskeletal organization but also nonautonomous effects via 
the up-regulation of these genes encoding a variety of secreted 
proteins, such as growth factors and chemokines. We show that 
fibroblast chemotaxis can be significantly affected by these se-
creted factors, depending on the precise experimental regimen. 
This finding resolves the contradictory findings of our group 
and Suraneni et al. (2012) on the role of the Arp2/3 complex 
during fibroblast chemotaxis (Wu et al., 2012). In hindsight, 
each group got the expected result for the experiment performed 
based on the exchange of fresh media or lack thereof in the 
Figure 5. Loss of Arp2/3 complex affects volume regulation and osmotic stress signaling. (A) Graph showing cell death rate of NS and 2×KD cells in 
hyperosmotic conditions. (B, left) Representative images showing Arp2-EGFP–expressing cells under iso- and hyperosmotic conditions. (right) Quanti-
fication of peripheral Arp2 under iso- and hyperosmotic conditions. ****, P < 0.001 by Student’s t test. Arp2-EGFP signals were identified manually, 
and its length versus the whole cell perimeter was defined as the peripheral Arp2 ratio and plotted. (C) Graph showing cell volume of NS and 2×KD 
cells in hypo (50% mixture of H2O and DMEM media)-, iso-, and hyper (0.25 M sorbitol-containing media)-osmotic conditions. ****, P < 0.001; **, 
P < 0.01 by Student’s t test. (D) Blot showing p-p38, p38, and GAPDH levels of NS and 2×KD cells under hyperosmotic conditions at different time 
points. (E) Blot showing p-p65, p65, p-p38, p38, and GAPDH levels of NS and 2×KD cells in hypoosmotic conditions at different time points. Fold 
changes in band intensity averaged across the three experiments (normalized to loading control and experimental control) are shown below each band. 
(F, i) Representative images showing endogenous p34Arc and F-actin (phalloidin) localization in the actin cortex. (ii) Representative images showing 
wild-type (WT) and 2×KD cells expressing Lifeact-EGFP. (iii) Fluorescent intensity profiles of the Lifeact signal near the cell edge were analyzed and 
plotted. Error bars show 95% CI. A.U., arbitrary unit.
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serum. After 48 h, we stimulated cells with 10% serum-containing media to 
induce cell division.
Cell volume measurement
Cells were trypsinized for 3 min until rounded and lifted from the culture 
dish. A gentle wash with sterile Dulbecco’s PBS was performed before re-
suspending cells in the indicated osmotic solutions for 20 min at room tem-
perature. Cells in suspension were imaged by differential interference 
contrast microscopy, and cell diameter was measured with ImageJ (Na-
tional Institutes of Health) to calculate cell volume.
Cell viability assay
Cells were plated on 10 µg/ml FN-coated glass-bottom culture dishes (Mat-
Tek Corporation) for 8–12 h before imaging. Propidium iodide was added 
to imaging dishes to a final concentration of 1 µg/ml. Time-lapse microscopy 
was performed on an incubator fluorescent microscope (20× objective; Viva-
View FL; Olympus) with a camera (ORCA-ER/AG type C4742-80-12AG; 
Hamamatsu Photonics). Fluorescent cells (indicating loss of membrane integ-
rity and cell death) were counted at the indicated time points. The curve of the 
percentage of cell death was generated with Prism (GraphPad Software).
ELISAs and CM
ELISA kits were as follows: IL-6 (eBioscience), MMP3 (RayBio), and HGF 
(Abcam). Cells were washed with serum-free DMEM and incubated in 
serum-free DMEM for 24 h. Media were collected and filtered before per-
forming ELISAs. All ELISA data are presented as absolute values based on 
standard curves from the kits.
Light microscopy and image analysis
Immunofluorescence. For immunofluorescent staining, the cells were fixed, 
stained, and mounted as described previously (Bear et al., 2002). 
Cells were plated on acid-washed coverslips coated with 10 µg/ml FN 
overnight before fixing with 4% PFA and permeabilized in 0.1% Triton 
X-100 in PBS for 5 min. To stain for p-p65, cells were prepermeabilized 
with 0.05% saponin for 45 s before fixation. Cells were stained with 
Alexa Fluor 647 phalloidin for F-actin (1:400 dilution), p-p65 (1:100; 
Cell Signaling Technology), and Hoechst (1:10,000). After three washes 
in PBS, the coverslips were mounted onto slides with Fluoromount-G 
(Electron Microscopy Sciences). Images were captured using an inverted 
microscope (IX81; Olympus) with a 60×, 1.42 NA objective, a charge-
coupled device camera (C4742-80-12AG), and an automated X-Y stage, 
with MetaMorph imaging software (Molecular Devices). Images were 
combined and annotated in Photoshop (Adobe) for presentation. To plot 
the distribution of a protein around the cell edge, a custom ImageJ macro 
was used to extract pixel intensity as a function of distance from the lead-
ing edge (Cai et al., 2007).
Nuclear CCM2 and p-p65 quantification. For CCM2, fluorescent time-
lapse images were taken with cells expressing YPET-CCM2 (Uhlik et al., 
2003) in cell culture media supplemented with trolox, ascorbic acid, and 
catalase under indicated conditions. Images were taken using an inverted 
microscope (IX81) with a 60×, 1.42 NA objective, a charge-coupled de-
vice camera (C4742-80-12AG), and an automated X-Y stage, operated by 
MetaMorph imaging software. Images at different time points were se-
lected, and the cell nucleus was outlined. Mean intensity of CCM2 signal 
within the outlined region was measured. Intensity was then normalized to 
time 0 and plotted using Prism. For p-p65 imaging, 20× fluorescent images 
were taken with fixed cells stained with p-p65 and Hoechst, cells with colo-
calization of p-p65 and Hoechst were counted, and fractions of cells with 
nuclear or cytoplasmic localization were plotted with Prism.
Peripheral Arp2 quantification. Fluorescent images were taken with 
the same imaging setup. Images were then processed with ImageJ soft-
ware. Arp2-EGFP signals near the cell edge were identified and drawn out 
with the freehand line function. The length l of the line was then measured 
and recorded. The perimeter of the same cell was measured the same way 
and recorded as L. The ratio of l/L was defined as the peripheral Arp2 
ratio for each cell.
Single-cell tracking. Cells were plated on 10 µg/ml FN-coated glass-
bottom culture dishes for 8–12 h before imaging. Time-lapse microscopy 
was performed on an incubator fluorescent microscope (20× objective; 
VivaView FL) with a camera (Orca ER/AG type c4742-80-12AG). Cell 
speed was measured with ImageJ using the Manual Tracking plug-in.
Directional migration assays
Microfluidic device preparation. Transparency masks were printed using 
a high-resolution printer (FineLine Imaging). The pattern for the chemo-
taxis chamber was fabricated on 4-inch silicon wafers using a two-step 
Materials and methods
Reagents and materials
Commercial antibodies were obtained from Cell Signaling Technology (AKT 
[pan], phospho-AKT [Ser473], p38 MAPK, phospho–p38 MAPK [Thr180/
Tyr182], NF-B p65, phospho–NF-B p65 [Ser536], and phospho-HSP27 
[Ser82]), EMD Millipore (p34Arc), Takara Bio Inc. (GFP), and Ambion/ 
Applied Biosystems (anti-GAPDH). Rhodamine red-X– and HRP-conjugated 
secondary antibodies were purchased from Jackson ImmunoResearch Lab-
oratories, Inc. Alexa Fluor 647 dye–conjugated phalloidin was obtained 
from Invitrogen. p38 MAPK inhibitor SB203580, Arp2/3 complex inhibitor 
CK666, and its inactive control CK689 were obtained from EMD Millipore 
and used at 100 µM. d-sorbitol is purchased from Sigma-Aldrich. Human 
plasma fibronectin (FN), PDGF-BB, and EGF were obtained from BD. West-
ern blotting was performed by standard techniques. Propidium iodide was 
obtained from Sigma-Aldrich. Two siRNAs targeted against siCCM2 were 
used (SI00943446 and SI00943453; QIAGEN). Protein A–Sepharose 
beads were obtained from Sigma-Aldrich.
RNA preparation, RNA-Seq, and qRT-PCR
Total RNA was isolated from cells (RNeasy Plus; QIAGEN) and validated 
to have RNA integrity numbers >8.5 using a bioanalyzer (2100 Bioana-
lyzer; Agilent Technologies). For RNA-Seq, poly(A)+ RNA was enriched 
(Oligotex mRNA Mini Kit; QIAGEN) and fragmented (RNA Fragmentation 
Reagents; Ambion), and cDNA was generated (SuperScript II; Invitrogen) 
by random priming followed by second strand synthesis (DNA Polymerase I; 
Enzymatics) and purified (PCR purification kit; QIAGEN). Libraries were 
prepared according to the manufacturer’s specifications (Illumina). Se-
quencing was performed using 50-bp single-end reads (HiSeq 2000; Illu-
mina). Reads were aligned to the reference mouse genome (mm9) using 
TopHat (Trapnell et al., 2009), and gene expression was estimated by cal-
culating RPKM (reads per kilobase per million reads; Mortazavi et al., 
2008) for all Ensembl genes, analyzing only exonic reads. For qRT-PCR, 
cDNA was generated from total RNA (SuperScript II) using a 50:50% mix-
ture of random primers (Invitrogen) and the oligo-dT primer (Promega). This 
cDNA was used directly with TaqMan Gene Expression Master Mix and 
TaqMan Gene Expression Assays (Applied Biosystems) to be read on a 
qRT-PCR machine (ViiA 7; Applied Biosystems). qRT-PCR data were ana-
lyzed by the Pfaffl method (Pfaffl, 2001).
Immunoprecipitation
Cell lysates were made in radioimmunoprecipitation assay buffer (50 mM 
Tris-HCl, pH 7.4, 1% NP-40, 0.5% Na-deoxycholate, 150 mM NaCl, and 
1 mM EDTA). An equal amount of each protein lysate was incubated/pre-
cleared with protein A–Sepharose beads and anti–rabbit-IgG antibody at 
4°C for 1 h. Cleared supernatants were then incubated with anti-p34Arc 
antibody or anti–rabbit-IgG antibody overnight at 4°C before adding pro-
tein A–Sepharose beads for an additional 2-h incubation. After washing 
the beads 2× with radioimmunoprecipitation assay buffer and 2× with 
PBS, immunoprecipitates were boiled in SDS sample buffer for immunoblot-
ting as indicated in legend of Fig. 4 G.
Western blotting
Western blotting was performed with standard protocol as previously de-
scribed (Cai et al., 2007). A representative blot from three experiments 
was shown for each figure. Fold changes in band intensity averaged 
across the three experiments (normalized to loading control and experi-
mental control) are shown below each band.
Cell culture and transient transfection
Cells were cultured in regular media (DMEM supplemented with 10% FBS 
[HyClone], 100 U/ml penicillin, 100 µg/ml streptomycin, and 292 µg/ml 
l-glutamine). DMEM supplemented with 0.1% fatty acid–free BSA (Equitech-
Bio), 100 U/ml penicillin, 100 µg/ml streptomycin, and 292 µg/ml l-glutamine 
was used to culture cells during serum starvation. Regular media contain-
ing 0.25 M sorbitol were used for the hyperosmotic condition. An equal vol-
ume of H2O supplemented with 10% FBS (HyClone), 100 U/ml penicillin, 
100 µg/ml streptomycin, and 292 µg/ml l-glutamine was added to regu-
lar media for the hypoosmotic condition. Transient transfections were per-
formed using X-tremeGENE 9 (Roche) for HEK293 FT cells and NanoJuice 
(EMD Millipore) for IA32 cells. siRNA transfection was performed with 
Lipofectamine RNAiMAX (Invitrogen).
Cell synchronization
To synchronize cells and enrich for cells undergoing mitosis, we washed 
cells twice with PBS at 30–40% cell confluency and added DMEM without 
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photolithography process. Polydimethylsiloxane (PDMS) was then poured 
on the wafer and cured overnight at 70°C. Individual PDMS devices were 
cut out from the wafer and placed in a clean dish until use. Ports were 
then punched out in the devices. The devices were washed with water and 
ethanol and blow dried. The PDMS device was placed into contact with a 
glass dish bottom immediately after plasma treatment of both pieces, ensur-
ing that an irreversible seal was formed. The cell culture chamber was then 
filled with 10 µg/ml FN for 1 h at 37°C followed by flushing with sterile 
PBS. Cells were loaded into the cell culture chamber using a gel-loading 
pipette tip. The cell chamber ports were plugged with short pieces of tub-
ing (0.0025 × 0.01325 inch; Upchurch Scientific).
Chemotactic gradients. The exit ports of the sink and source channels 
were connected to waste using tubing of an internal diameter of 0.015 
inches. Gas tight 100-µl glass syringes (100-µl syringe; 81020 1710TLL; 
Hamilton) were connected to 27.5-gauge needles connected to tubing. The 
source syringe and tubing were filled with the indicated CM containing the 
indicated chemoattractant and 10 µg/ml TRITC-dextran to visualize the gra-
dient. The sink syringe and tubing were filled with the indicated CM only. 
The tubing was then inserted into the source and sink channels, respectively, 
and the syringe pump was operated at a flow rate of 20 nl/min. A stable 
gradient was then established in the cell culture chamber within 30 min, and 
typically remained stable for 18 h as monitored by TRITC-dextran fluorescent 
intensity. In PDGF chemotaxis experiments, the source concentration of PDGF 
was 120 ng/ml, whereas in EGF chemotaxis experiments, 100 ng/ml EGF 
was in the source chamber.
Directional migration image acquisition and analysis. Chemotaxis as-
says were performed on an inverted microscope (IX81) with a camera 
(Orca-ER) operated by MetaMorph imaging software. A 20× objective 
was used. Images were collected every 10 min for over 12 h. Individual 
cells were manually tracked using ImageJ software Manual Tracking plug-
in. The tracks obtained were further analyzed using the chemotaxis tool 
developed by ibidi. This analysis tool was used to extract the forward mi-
gration index and histogram of angular direction of tracks from the manual 
tracking results. To obtain the compass parameter, the histograms obtained 
were further analyzed in Prism software by performing a nonlinear curve fit 
to the chemotaxis equation.
Online supplemental material
Fig. S1 shows that NF-B is activated in Arp2/3-inhibited cells and regu-
lates the secretory phenotype in Arp2/3-deficient or -inhibited cells. Fig. S2 
show that p38 MAPK and the MEKK3–OSM complex are involved in 
the secretory phenotype in Arp2/3-deficient or -inhibited cells. Video 1 
shows a representative cell expressing Arp2-GFP (with Arp2 depletion) 
treated with sorbitol to induce hyperosmotic stress. Table S1 is pro-
vided as an Excel (Microsoft) file and shows the RNA-Seq results of 
this study. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201306032/DC1.
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